[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"thyroid-disease-pregnancy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:thyroid-disease-pregnancy":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":23,"studyType":24,"phases":4,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100602620","gongji-pregnancy-endorine-cohort-study-100602620",false,"NCT07125885","Gongji Pregnancy Endorine Cohort Study","Serological, Metabolomic, and Genomic Studies of Endocrine Disorders in Pregnancy","GREAT","Inclusion Criteria:\n\n* Women preparing for pregnancy or pregnant women or within 1 year after giving birth\n* Age ≥ 18 years old\n* Signed the informed consent form to voluntarily enroll in the management follow-up\n\nExclusion Criteria:\n\n* Individuals who are unable to communicate normally and those who are unwilling to cooperate\n* Pregnant women with severe organic diseases or mental illnesses\n* Any condition deemed by the investigator to affect eligibility for the study","FEMALE","18 Years","50 Years",{"count":21,"type":22},3000,"ESTIMATED","10 Years","OBSERVATIONAL","To explore the relationship between genetic factors, lifestyle, and drug interventions and the occurrence, development, adverse pregnancy outcomes, and postpartum maternal-infant outcomes of gestational endocrine diseases.",[27,28,29],"Gestatiaonl Diabetes Mellitus","Thyroid Disease Pregnancy","Hyperglycemia in Pregnant Diabetic Patients","RECRUITING","2025-08-09",{"date":33,"type":34},"2025-08-15","ACTUAL",{"date":36,"type":34},"2023-05-05",{"date":38,"type":22},"2043-12-31",{"name":40,"class":41},"Shanghai General Hospital, China","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":24,"phases":4,"briefSummary":52,"conditions":53,"keywords":54,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":5},"100576709","prenatal-ultrasonographic-assessment-of-fetal-thyroid-in-patients-with-thyroid-pathology-100576709","NCT06788821","Prenatal Ultrasonographic Assessment of Fetal Thyroid in Patients With Thyroid Pathology","Inclusion Criteria:\n\n* Participants between 14 and 37 gestational weeks, who will be followed for the entire period of pregnancy, up to delivery, at the same enrolling center\n* Obtaining informed consent for participation in the study\n* Maternal age between 18 and 45 years (extremes included)\n* Participants with good understanding of the Italian language\n\nExclusion Criteria:\n\n* Smoking participants\n* Patients with BMI\\>30\n* Absence of correct dating of pregnancy within the first trimester\n* Pathological conditions (e.g., malabsorptive or socioeconomic conditions that may interfere with fetal growth)\n* Twin pregnancy\n* Only for the low obstetric risk group of patients: Fetus with malformative pathology","45 Years",{"count":51,"type":22},440,"The goal of this observational study is to evaluate the possibility to use prenatal ultrasonography for diagnosis and prognostic guidance in cases of suspected fetal thyroid changes in fetuses belonging to women with thyroid disease and women with low obstetric risk (i.e., pregnancy not complicated by maternal and\u002For fetal pathology) between 14 and 37 gestational weeks.\n\nThe main question it aims to answer is:\n\nIs it possible to diagnose thyroid disease in fetuses early using measurable parameters of the fetal thyroid through ultrasonography?",[28],[55],"fetal thyroid","2025-01-28",{"date":58,"type":34},"2025-01-29",{"date":60,"type":34},"2024-06-12",{"date":62,"type":22},"2026-03-01",{"name":64,"class":41},"IRCCS Azienda Ospedaliero-Universitaria di Bologna"]